|
1
|
Hofer CC, Woods PS and Davis IC: Infection
of mice with influenza A/WSN/33 (H1N1) virus alters alveolar type Ⅱ
cell phenotype. Am J Physiol Lung Cell Mol Physiol. 308:L628–L638.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Liu Y, Kumar VS, Zhang W, Rehman J and
Malik AB: Activation of type Ⅱ cells into regenerative stem cell
antigen-1(+) cells during alveolar repair. Am J Respir Cell Mol
Biol. 53:113–124. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schmiedl A, Kerber-Momot T, Munder A,
Pabst R and Tschernig T: Bacterial distribution in lung parenchyma
early after pulmonary infection with Pseudomonas aeruginosa.
Cell Tissue Res. 342:67–73. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tumurkhuu G, Dagvadorj J, Jones HD, Chen
S, Shimada K, Crother TR and Arditi M: Alternatively spliced
myeloid differentiation protein-2 inhibits TLR4-mediated lung
inflammation. J Immunol. 194:1686–1694. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hartshorn KL: Role of surfactant protein A
and D (SP-A and SP-D) in human antiviral host defense. Front Biosci
(Schol Ed). 2:527–546. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Ariki S, Nishitani C and Kuroki Y: Diverse
functions of pulmonary collectins in host defense of the lung. J
Biomed Biotechnol. 2012(532071)2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Beutler B: Inferences, questions and
possibilities in Toll-like receptor signalling. Nature.
430:257–263. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Takeuchi O, Hoshino K, Kawai T, Sanjo H,
Takada H, Ogawa T, Takeda K and Akira S: Differential roles of TLR2
and TLR4 in recognition of gram-negative and gram-positive
bacterial cell wall components. Immunity. 11:443–451.
1999.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hoshino K, Tsutsui H, Kawai T, Takeda K,
Nakanishi K, Takeda Y and Akira S: Cutting edge: generation of
IL-18 receptor-deficient mice: evidence for IL-1 receptor-related
protein as an essential IL-18 binding receptor. J Immunol.
162:5041–5044. 1999.PubMed/NCBI
|
|
10
|
Hayashi F, Smith KD, Ozinsky A, Hawn TR,
Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM and Aderem A: The
innate immune response to bacterial flagellin is mediated by
Toll-like receptor 5. Nature. 410:1099–1103. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Heil F, Hemmi H, Hochrein H, Ampenberger
F, Kirschning C, Akira S, Lipford G, Wagner H and Bauer S:
Species-specific recognition of single-stranded RNA via toll-like
receptor 7 and 8. Science. 303:1526–1529. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Ricard JD, Dreyfuss D and Saumon G:
Production of inflammatory cytokines in ventilator-induced lung
injury: A reappraisal. Am J Respir Crit Care Med. 163:1176–1180.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kawai T, Takeuchi O, Fujita T, Inoue J,
Mühlradt PF, Sato S, Hoshino K and Akira S: Lipopolysaccharide
stimulates the MyD88-independent pathway and results in activation
of IFN-regulatory factor 3 and the expression of a subset of
lipopolysaccharide-inducible genes. J Immunol. 167:5887–5894.
2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Barton GM and Medzhitov R: Toll-like
receptor signaling pathways. Science. 300:1524–1525.
2003.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cyr SL, Angers I, Guillot L,
Stoica-Popescu I, Lussier M, Qureshi S, Burt DS and Ward BJ: TLR4
and MyD88 control protection and pulmonary granulocytic recruitment
in a murine intranasal RSV immunization and challenge model.
Vaccine. 27:421–430. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhou B, Zhou H, Ling S, Guo D, Yan Y, Zhou
F and Wu Y: Activation of PAR2 or/and TLR4 promotes SW620 cell
proliferation and migration via phosphorylation of ERK1/2. Oncol
Rep. 25:503–511. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yan ZQ: Regulation of TLR4 expression is a
tale about tail. Arterioscler Thromb Vasc Biol. 26:2582–2584.
2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Gui J, Yue Y, Chen R, Xu W and Xiong S:
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting
NF-κB signaling. PLoS One. 7(e46515)2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Janssen R, Pennings J, Hodemaekers H,
Buisman A, van Oosten M, de Rond L, Oztürk K, Dormans J, Kimman T
and Hoebee B: Host transcription profiles upon primary respiratory
syncytial virus infection. J Virol. 81:5958–5967. 2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lizundia R, Sauter KS, Taylor G and
Werling D: Host species- specific usage of the TLR4-LPS receptor
complex. Innate Immun. 14:223–231. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Baschant U and Tuckermann J: The role of
the glucocorticoid receptor in inflammation and immunity. J Steroid
Biochem Mol Biol. 120:69–75. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wei SD, Li JZ, Liu ZJ, Chen Q, Chen Y,
Chen M and Gong JP: Dexamethasone attenuates
lipopolysaccharide-induced liver injury by downregulating
glucocorticoid-induced tumor necrosis factor receptor ligand in
Kupffer cells. Hepatol Res. 41:989–999. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pizzi M: Sampling variation of the fifty
percent end-point, determined by the Reed-Muench (Behrens) method.
Hum Biol. 22:151–190. 1950.PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Delgado MF, Coviello S, Monsalvo AC,
Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY,
Mitzner W, et al: Lack of antibody affinity maturation due to poor
Toll-like receptor stimulation leads to enhanced respiratory
syncytial virus disease. Nat Med. 15:34–41. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Caratti G, Matthews L, Poolman T and
Kershaw S: Baxter MA and Ray D: Glucocorticoid receptor function in
health and disease. Clin Endocrinol (Oxf). 4:185–193. 1997.
|
|
28
|
Oakley RH, Jewell CM, Yudt MR, Bofetiado
DM and Cidlowski JA: The dominant negative activity of the human
glucocorticoid receptor beta isoform. Specificity and mechanisms of
action. J Biol Chem. 274:27857–27866. 1999.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zen M, Canova M, Campana C, Bettio S,
Nalotto L, Rampudda M, Ramonda R, Iaccarino L and Doria A: The
kaleidoscope of glucorticoid effects on immune system. Autoimmun
Rev. 10:305–310. 2011.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kamiyama K, Matsuda N, Yamamoto S, Takano
K, Takano Y, Yamazaki H, Kageyama S, Yokoo H, Nagata T, Hatakeyama
N, et al: Modulation of glucocorticoid receptor expression,
inflammation, and cell apoptosis in septic guinea pig lungs using
methylprednisolone. Am J Physiol Lung Cell Mol Physiol.
295:L998–L1006. 2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bhattacharyya S, Brown DE, Brewer JA, Vogt
SK and Muglia LJ: Macrophage glucocorticoid receptors regulate
Toll-like receptor 4-mediated inflammatory responses by selective
inhibition of p38 MAP kinase. Blood. 109:4313–4319. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Vollmer TR, Stockhausen A and Zhang JZ:
Anti-inflammatory effects of mapracorat, a novel selective
glucocorticoid receptor agonist, is partially mediated by MAP
kinase phosphatase-1 (MKP-1). J Biol Chem. 287:35212–35221.
2012.PubMed/NCBI View Article : Google Scholar
|
